Advancing SCS Therapies
Boston Scientific advanced the science of spinal cord stimulation by introducing Combination therapy – the ability to engage multiple mechanisms of action simultaneously. We have taken that advancement a step further by targeting a new, distinct SCS mechanism of action with FAST™.1
Paresthesia-Free Pain Relief in Minutes with FAST
Now patients can experience significant results before they leave your clinic, giving you and your patients confidence in their SCS therapy.
- Targets surround inhibition: a new distinct SCS MOA1
- Maximizes your patients' SCS experience
- Available in both the trial and permanent implant
Broad Coverage. Greater Efficiency.
Our optimized Contour™ Therapy delivers broad paresthesia-free coverage across multiple neural targets – now with enhanced energy efficiency.
- Optimized to use less energy than conventional paresthesia-free therapies2
- Personalized to each patient's unique anatomy
- Designed to mitigate loss of therapy due to lead migration
Combination Therapies. Amplify Success.
Not only does WaveWriter Alpha offer some of the latest in advanced therapies, but Boston Scientific is the only company that can deliver therapies simultaneously for lasting relief that’s tailored to every patient’s needs.
Supported by Ongoing Comprehensive Clinical Evidence
Our clinical studies have shown significant and sustained pain relief, improved disability index and increased patient satisfaction.
Subscribe for Updates
Receive timely access to major announcements, opportunities to connect with your peers through educational events and useful tools for you to help more patients.
Ready to Talk to Someone about Alpha?
Have us contact you to learn more about WaveWriter Alpha and other pain management innovations and implanted pain stimulators.
Pain.com: Chronic Pain Educare for Patients
Do your patients need educational resources about chronic pain? Direct them to our pain.com website, where they can learn about implanted spinal cord stimulation devices and other treatment options.